EMAIL THIS PAGE TO A FRIEND

PloS one

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.


PMID 26554929

Abstract

The aim of this study was to further characterize pharmacological properties of two phenylpiperazine derivatives: 1-{2-[2-(2,6-dimethlphenoxy)ethoxy]ethyl}-4-(2-methoxyphenyl)piperazynine hydrochloride (HBK-14) and 2-[2-(2-chloro-6-methylphenoxy)ethoxy]ethyl-4-(2- methoxyphenyl)piperazynine dihydrochloride (HBK-15) in radioligand binding and functional in vitro assays as well as in vivo models. Antidepressant-like properties were investigated in the forced swim test (FST) in mice and rats. Anxiolytic-like activity was evaluated in the four-plate test in mice and elevated plus maze test (EPM) in rats. Imipramine and escitalopram were used as reference drugs in the FST, and diazepam was used as a standard anxiolytic drug in animal models of anxiety. Our results indicate that HBK-14 and HBK-15 possess high or moderate affinity for serotonergic 5-HT2, adrenergic α1, and dopaminergic D2 receptors as well as being full 5-HT1A and 5-HT7 receptor antagonists. We also present their potent antidepressant-like activity (HBK-14-FST mice: 2.5 and 5 mg/kg; FST rats: 5 mg/kg) and (HBK-15-FST mice: 1.25, 2.5 and 5 mg/kg; FST rats: 1.25 and 2.5 mg/kg). We show that HBK-14 (four-plate test: 2.5 and 5 mg/kg; EPM: 2.5 mg/kg) and HBK-15 (four-plate test: 2.5 and 5 mg/kg; EPM: 5 mg/kg) possess anxiolytic-like properties. Among the two, HBK-15 has stronger antidepressant-like properties, and HBK-14 displays greater anxiolytic-like activity. Lastly, we demonstrate the involvement of serotonergic system, particularly 5-HT1A receptor, in the antidepressant- and anxiolytic-like actions of investigated compounds.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

74875
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
C24H21Na3O11S3
A9501
Adenosine 3′,5′-cyclic monophosphate, ≥98.5% (HPLC), powder
C10H12N5O6P
A3262
Adenosine 3′,5′-cyclic monophosphate tris salt, ≥97% (HPLC), powder
C10H12N5O6P · C4H11NO3
D0899
Diazepam
C16H13ClN2O
D-907
Diazepam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
C16H13ClN2O
07-4860
Dimethyl sulfoxide, JIS special grade, ≥99.0%
C2H6OS
07-4871
Dimethyl sulfoxide, for HPLC
C2H6OS
G2289
Glycerin, meets USP testing specifications
C3H8O3
G5516
Glycerol, for molecular biology, ≥99.0%
C3H8O3
G6279
Glycerol, BioXtra, ≥99% (GC)
C3H8O3
G9012
Glycerol, ≥99.5%
C3H8O3
G2025
Glycerol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
C3H8O3
49767
Glycerol, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
C3H8O3
W252506
Glycerol, FCC, FG
C3H8O3
49781
Glycerol solution, 86-89% (T)
C3H8O3 · xH2O
H1512
Haloperidol, powder
C21H23ClFNO2
H100
Haloperidol
C21H23ClFNO2
RDD002
HEPES, anhydrous, free-flowing, Redi-Dri, ≥99.5%
C8H18N2O4S
H3375
HEPES, ≥99.5% (titration)
C8H18N2O4S
H4034
HEPES, BioPerformance Certified, ≥99.5% (titration), cell culture tested
C8H18N2O4S
PHG0001
HEPES, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture
C8H18N2O4S
RES6003H-B7
HEPES, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture
C8H18N2O4S
H7523
HEPES, BioXtra, pH 5.0-6.5 (1 M in H2O), ≥99.5% (titration)
C8H18N2O4S
H6147
HEPES, BioXtra, suitable for mouse embryo cell culture, ≥99.5% (titration)
C8H18N2O4S
54457
HEPES, BioUltra, for molecular biology, ≥99.5% (T)
C8H18N2O4S
83264
HEPES buffer solution, 1 M in H2O
C8H18N2O4S
A5960
L-Ascorbic acid, BioXtra, ≥99.0%, crystalline
C6H8O6
A7506
L-Ascorbic acid, reagent grade, crystalline
C6H8O6
A0278
L-Ascorbic acid, reagent grade
C6H8O6
A4403
L-Ascorbic acid, powder, cell culture tested, γ-irradiated
C6H8O6